Categories: Invest

Should you buy Altria Group shares in June?

Altria Group, Inc. (NYSE: MO) shares have advanced more than 20% since the beginning of January 2021, and the current share price stands around $49.50. Altria is a stable company with a good position in the market, while its shares could be a good choice for any investor seeking secure dividend income.

Fundamental analysis: Altria expects adjusted diluted EPS in the range of $4.49 to $4.62 for the 2021 fiscal year

Altria Group is an American corporation and one of the world’s largest producers and marketers of tobacco, cigarettes, and related products. Altria Group is previously known as Philip Morris Companies, and according to estimates, this company could expand its market share even more in the upcoming years.


Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

Altria Group has a strong demand for its products and the right management team to scale and improve efficiency. Morgan Stanley reported this week that shares of this company should move “upside from the current levels” as an FTC administrative trial is set to begin this week.

Altria reported its first-quarter results in the last week of April; total revenue has decreased by -3.4% Y/Y to $4.88 billion, while the non-GAAP EPS was $1.07 (beats by $0.02). Total revenue has decreased above the expectations (-$110 million) mainly due to the Covid-19 pandemic, and the company reaffirmed its guidance for 2021 full-year.

Altria expects adjusted diluted EPS in the range of $4.49 to $4.62 for the 2021 fiscal year, representing a growth rate of 3% to 6% from an adjusted diluted EPS of $4.36 in the 2020 fiscal year. Altria began the second quarter in a strong position, but some negative news could hit the profitability and revenues in the upcoming quarters.

According to the rumors, the Biden administration may raise excise taxes on cigarettes which would certainly negatively influence the business of Altria. Financial and research company Argus lowered its rating on Altria Group to hold from a buy and reported that it expects lower adjusted EPS from Altria.

“In particular, the FDA recently said that it planned to ban menthol cigarettes and was considering rules that would reduce cigarette nicotine to nonaddictive levels. In addition, the Biden administration may raise excise taxes on cigarettes,” said Kristina Ruggeri, an analyst from Argus.

Despite this, Altria Group shares are still undervalued relative to the market, and this company could deliver substantial shareholder value for many years to come. Altria trades at less than ten times 2020 EBITDA, the dividend yield is around 6.97% at the current share price, and with a market capitalization of $91 billion, shares of this company are not expensive.

Technical analysis: $50 represents the first resistance level

Data source: tradingview.com

If the price jumps above $50 resistance, it would be a signal to trade shares, and the next target could be around $52. Rising above $54 supports the continuation of the bullish trend for Altria shares, but if the price falls below $44, it would be a strong “sell” signal.

Summary

Altria trades at less than ten times 2020 EBITDA, and its shares could be a good choice for any investor seeking secure dividend income. Altria Group shares continue to be supported, and for now, everything indicates that the price could stabilize soon above the $50 resistance level.

Invest in crypto, stocks, ETFs & more in minutes with our preferred broker,

eToro







7/10

67% of retail CFD accounts lose money

admin

Share
Published by
admin

Recent Posts

Is there a way for the crypto sector to avoid Bitcoin’s halving-related bear markets?

There is good reason to be afraid. Previous down markets have seen declines in excess…

2 years ago

UPS and FedEx are good dividend stocks, but which should you take?

United Parcel Service, Inc. (NYSE:UPS) and FedEx Corporation (NYSE:FDX) are two robust logistics companies. Both…

2 years ago

Bitfarms sold 3K Bitcoin as part of strategy to improve liquidity and pay debts

Canadian crypto mining firm Bitfarms sold roughly $62 million worth of Bitcoin (BTC) in June,…

2 years ago

This biotech stock is up 100% on Tuesday: here’s the catalyst

Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling…

2 years ago

Japanese film studio announces the production of a series based on crypto

Noma, a Japanese film studio, has announced that it is producing three feature films that…

2 years ago

Bitcoin price taps 5-day highs as Shiba Inu leads altcoin gains

Bitcoin (BTC) saw continued strength on June 21 as Wall Street trading opened with a…

2 years ago